Alert/Advisory
Alerts provide important advice about health products that may include safety information.
Latest alerts
-
Consumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
-
We have made a new Serious Scarcity Substitution Instrument to help manage the shortage and upcoming discontinuation of Ryzodeg 70/30 FlexTouch insulin.
-
We have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
Latest articles
-
Azithromycin and rare risk of cardiovascular death
An updated warning about the risk of sudden cardiovascular death has been added to the Product Information and Consumer Medicine Information documents for azithromycin. -
Updated warnings about persistent sexual dysfunction for antidepressants
The Product Information documents for antidepressants have been updated with warnings about sexual dysfunction continuing in some patients, after they stop using the medicines. -
Scam alert
We are aware that a small number of people have received calls from scammers impersonating the TGA.
Latest publications
-
In consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
TGA Laboratories has released a report detailing testing of alkyl nitrite products